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C I I A P T T R  6
Atrial fibrillation and flutter are common arrhythmias, especially the former.
Neurohumoral factors play an important role in the genesis and maintenance of
these arrhythmias. In particular, vagal stimulation per se may evoke acute parox-
ysmal atrial fibrillation and flutter by modiS'ing atrial electrophysiologic proper-
ties. Sympathetic activity may also elicit these arrhythmias in patients with oth-
erwise healthy hearts. However, in clinical practice this type of arrhythmia is less
important than its vagal counterpart; instead, sympathetic stimulation appears to
play a more prominent role in paroxysmal atrial fibrillation in patients with struc-
tural heart disease, particularly ischemic heart disease. Presumably, the effects of
sympathetic stimulation on atrial electrophysiology are mediated mainly through
associated hemodynamic eÍfects ("contraction-excitation feedback"). Once the
arrhythmia has developed, vagal and sympathetic tone profoundly affect the
ventricular rate. Conversely, atrial fibrillation and flutter also affect the auto-
nomic nervous system. Acute arrhythmia, by instantaneously aÍfecting hemodyna-
mic status, causes transient sympathetic activation, or alternatively, may elicit a
vasovagal response. AIso, atrial natriuretic peptide (ANP) secretion is acutely
augmented.'[/.hereas in paroxysmal lone atrial fibrillation and flutter vagal activ-
ity is often implicated, in chronic arrhlthmia the sympathetic nervous system
plays a very important role. Chronic atrial fibrillation and flutter may lead to
heart failure, especially when ventricular rate is poorly controlled ("tachycardi-
omyopathy"), which in turn causes neurohumoral activation, including sympa-
thetic activation. Conversely, rate control is often hampered by excessive sympa-
thetic activation in the setting of mild left ventricular dysfunction. Finally, it is
well established that heart failure is an important risk factor for development of
atrial fibrillation. It appears that associated neurohumoral activation may be a
contributing factor. In this thesis some aspects of this reciprocal relation between
atrial fibrillation and flutter and neurohumoral mechanisms were investieated.
The results are presented in Appendices 1-10.
The clinical hallmark of atrial fibrillation is an irregular ("random") ventricular
rhythm. Randomness of atrial rhythm is generally considered to account for this
phenomenon. However, as yet the evidence is merely circumstantial. We spe-
cifically addressed this issue in Appendix 1. Randomness of the distribution of
AA-intervals and RR-intervals was examined in pigs with metacholine and pac-
ing-induced atrial fibrillation, using autocorrelation analysis. In nine out of ten
pigs both atrial and ventricular intervals proved to be randomly distributed. In
the remaining pig the distribution of both the atrial and ventricular intervals was
nonrandom. Inspection of the original recordings revealed that this was due to
transition of atrial fibrillation to atrial flutter with 2:1 AV block. These findings
support the belief that randomness of the heart beat in atrial fibrillation is due to
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S U M M A R Y  A N D  N E W  V I S T A S
Though the heart-rate-lowering eÍfect of B-blockers in atrial fibrillation is gen-
erally attributed solely to a direct depressant effect on AV conduction, no studies
have actually investigated the underlying mechanism. In particular, the effect of
B-blockade on atrial fibrillatory activity is unknown. We investigated the eÍfect of
metoprolol on AV conduction and atrial fibrillatory rate in open-chest pigs with
metacholine and pacing-induced atrial fibrillation. Results are reported in Ap-
pendix 2. Metoprolol prolonged AV-nodal refractoriness both during sinus
rhythm and atrial fibrillation. Interestingly, metoprolol significantly decreased
atrial fibrillatory rate. This decrease far exceeded the prolongation of atrial
refractoriness after metoprolol during sinus rhlthm. Indexes of concealed AV-
nodal conduction were unchanged after r.netoprolol. These findings support the
contention that the eÍfect ofB-blockers on the ventricular reponse to atrial fibril-
lation is due to direct prolongation ofAV-nodal refractoriness. Furthermore, the
data suggest hat metoprolol has anti-fibrillatory properties, which may in part
be due to a rate-dependent, class I effect on atrial refractoriness.
In Appendix 3 a patient is described with features suggestive of "vagal" atrial
fibrillation, based on the history and Holter recordings. Analysis of heart rate
variabilitywas performed to further analyze the role of the autonomic nervous
system. Findings were compatible with vagally-mediated arrhythmia: preceding
the actual onset of atrial fibrillation, heart rate variability parameters of vagal
activity markedly increased. The patient was then started on disopyramide, be-
cause of its strong anticholinergic effects. This therapy caused almost total relief
of symptoms. Analysis of heart rate variability confirmed the vagolytic effects of
disopyramide. This case suggests that analysis of heart rate variability may be a
useful tool in the work-up and therapeutic management of patients with parox-
ysmal atrial fibrillation.
Appendix 4 reports on tvvo patients with reproducible post-exertional slmcope
due to prolonged asystole. In one of these patients asystole was frequently suc-
ceeded by atrial fibrillation. No structural heart disease was demonstrable in ei-
ther patient. At tilt-table testing no abnormal heart rate and blood pressure re-
sponses were noted, suggesting thatvasovagal mechanisms were not implicated.
However, heart rate variability during Holter monitoring was indicative of a high
vagal tone. Strong vagotonia was also noted during electrophysiologic testing. In
addition, atrial Íibrillation was elicited several times during programmed stimu-
lation in both patients under basal conditions, but not after pharmacologic auto-
nomic blockade. These findings suggest hat in asystole post-exercise excessive
(rebound) vagal tone plays an important role. Also, the data confirm that strong
vagal stimulation per se may precipitate atrial fibrillation in healthy subjects.
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Clinical practice provides abundant evidence of strong vagal effects on ventricu-
lar rhythm in patients with atrial fibrillation. Animal studies suggest that en-
hanced concealed AV-nodal conduction through augmented fibrillatory activity
is involved (in addition to a direct depressant effect on the AV node).'We exam-
ined whether also in clinical atrial fibrillation augmented concealed conduction
contributes to the heart- rate-lowering effect of vagal stimulation. Thus, the eÊ
fect of methylatropine (after pretreatment with propranolol) on ventricular-
intervals was studied in a group of patients with chronic atrial fibrillation. The
ratio of the longest to the shortest ventricular interval and the coefficient of
variation of ventricular intervals were used as indexes of concealed conduction.
Results are presented in Appendix 5. After methylatropine, noninvasive para-
meters of concealed conduction were significantly reduced compared to base-
line. This study suggests that the vagal effect on ventricular rate during clinical
atrial fibrillation is indeed mediated in part by augmenting concealed AV-nodal
conduction.
To investigate the role of synpathetic activation in evoking atrial fibrillation, a
database of approximately 12000 consecutive, unselected exercise tests was re-
viewed. Results are presented inAppendix 6. Atrial fibrillation developed in 14
patients during exercise and in nine patients during recovery In six patients (26%)
no structural heart disease was apparent. Compared with controls matched for
age, sex, and test indication, patients who developed atrial fibrillation used B-
blockers less frequently and had a higher maximal heart rate. Also, these patients
more often had an ischemic response to exercise. These data support the concept
that strong sympathetic stimulation may provoke atrial fibrillation in susceptible
subjects. However, most patients with exercise-induced arrhlthmia have under-
lying structural heart disease.
Though atrial rate during atrial flutter is traditionally considered constant, sub-
tle variations may nevertheless occur. Besides antiarrhythmic drugs, changes in
atrial load and autonomic status may affect flutter rate. We investigated the effect
of exercise on flutter rate in patients with chronic atrial flutter. Results are re-
ported in Appendix 7. At maximal exercise, flutter cycle length was slightly
increased in the majority of patients. Increases developed in patients both with
andwithout digoxin and irrespective ofdevelopment of 1:l AVconduction. These
findings support the concept that changes in atrial load may affect atriil flutter
rate. As such, this represents an example of contraction-excitation feedback at
the atrial level. V/ithdrawal ofvagal tone during exercise does not appear to play
an important role. The results are clinically relevant, since increases in cycle
length facilitate 1: 1 AV conduction, leading to inordinately high ventricular rates.
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S U M M A R Y  A N D  N E W  V I S T A S
The initial heart rate response to exercise in patients with atrial fibrillation often
is excessive. It was hlryothesized that especially patients with poor functional
cepacity would exhibit such a response. This hypothesis was based on observa-
tions in patients in sinus rhythm with left ventricular dysfunction. In these pa-
tients minor exercise is associated with excessive sympathetic activation. Thus,
the relation between functional capaciq (measured by peak VOr) and the heart
rate response at different levels of exercise was investigated in a large group of
petients with chronic atrial fibrillation. Results are reported inAppendix 8. On
the average, patients with impaired functional capaciry had higher heart rates
than patients with preserved functional capacity during minor exercise, despite
similar heart rates at rest. In patients on B-blockers this differential response was
not observed. These findings confirmed our initial hypothesis. It is feasible that
excessive heart rates during minor exercise have a deleterious effect on left ven-
tricular function and may lead to tachycardiomyopathy.
In Appendix 9 a case is described of a 43-year-old male with tachycardiomyo-
pathy, who was succesfully treated with low dose B-blocker. The patient pre-
sented with severe congestive heart failure and atrial fibrillation with a rapid
ventricular response. Despite treatmentwith diuretics, captopril, nitrates, digoxin,
and diltiazem the clinical condition only marginally improved and heart rate
remained poorly controlled. At exercise testing high norepinephrine levels were
found at rest and particularly at a low level of exercise. After additional treatment
with metoprolol, titrated against heart rate, the patient improved remarkably
Left ventricular function and exercise capacity were almost fully restored. Moreo-
ver, norepinephrine levels at rest and during exercise normalized. This case sug-
gests that neurohumoral activation may play an important role in the pathoge-
nesis of tachycardiomyopathy
A reciprocal relation exists between atrial fibrillation and heart failure: atrial
fibrillation may precipitate heart failure and vice versa. Neurohumoral activa-
tion and inadequate rate control may play an important role in this respect. We
assessed the effect of lisinopril in patients with heart failure and chronic atrial
fibrillation in a randomized, placebo-controlled trial. The results are reported in
Appendix 10. Tieatment with lisinopril was associated with a significant in-
crease in peak VOr. Also, norepinephrine levels during exercise tended to be
lower, as well as heart rate. Left ventricular fractional shortening tended to im-
prove. Left atrial size was unaffected, as were ANP levels. Finally, there was a
trend towards improved maintenance of sinus rhythm after cardioversion in pa-
tients treated with lisinopril. These findings support the key role of neurohumoral
activation in the recipocal relation between heart failure and atrial fibrillation, as
well as the concept of "concealed" tachycardiomyopathy
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Clinical implications and possible future directions.From an epidemiologic
point of view both heart failure and atrial fibrillation will become increasingly
important. Betvveen atrial fibrillation and heart failure an intricate, reciprocal
relation exists. On the one hand atrial fibrillation may precipitate or worsen heart
failure, and on the other hand, heart failure increases the propensity for atrial
fibrillation and complicates adequate treatment. From this thesis, it appears that
neurohumoral mechanisms are implicated in either process. In the case of mere
left ventricular dysfunction, sympathetic activation may facilitate the transition
to overt heart failure through promoting tachycardiomyopathy. Once overt heart
failure has developed, sympathetic activation further hampers rate control. In
addition, itpresumablyincreases the likelihood ofdevelopmentofatrial fibrillation
in the setting of heart failure, including recurrence of atrial fibrillation after
cardioversion. The therapeutical implications are manifold. Adequate control of
ventricular rate is essential in patients with chronic atrial fibrillation, especially
when left ventricular function is already impaired. Particular attention should be
paid to heart rate at low levels of exercise. Furthermore, in patients with overt
heart failure and atrial fibrillation optimization of left ventricular function and
reversal of sympathetic activation should be considered first, before attempting
cardioversion. In otherwords, sympathetic activation per se is a target for therapy.
Obviously, agents with anti-adrenergic properties (B-blockers, angiotensin con-
verting enzyme-inhibitors) are most promising in this respect. As to future re-
search, the concept of concealed tachycardiomyopathy in particular needs fur-
ther validation. The following study-design is proposed. Patients in whom
functional capacity is (still) preserved, but with inappropriate rate control should
be followed up and compared to patients with adequate rate control. If func-
tional capacity is already impaired, the effect of rate control using a B-blocker
should be investigated.
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